Glenmark Pharmaceuticals Inc., USA recalls Zonisamide Capsules, USP, 50 mg, packaged in 100-count bottles, Rx only, Manufactured by: Glenmark Pharmaceuticals, Inc.
Recalled May 4, 2022 · FDA recall D-0792-2022 · Glenmark Pharmaceuticals Inc., USA
Hazard
cGMP deviations · FDA Class II
Units
12,003 bottles
Sold at
USA nationwide
Description
cGMP deviations
Product
Zonisamide Capsules, USP, 50 mg, packaged in 100-count bottles, Rx only, Manufactured by: Glenmark Pharmaceuticals, Inc., USA Monroe, NC 28110, Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430, NDC 68462-129-01
Manufacturer(s)
Glenmark Pharmaceuticals Inc., USA
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →